Empagliflozin monotherapy with sitagliptin as an active comparator in patients with type 2 diabetes: a randomised, double-blind, placebo-controlled, phase 3 trial
Titel:
Empagliflozin monotherapy with sitagliptin as an active comparator in patients with type 2 diabetes: a randomised, double-blind, placebo-controlled, phase 3 trial
Auteur:
Roden, Michael Weng, Jianping Eilbracht, Jens Delafont, Bruno Kim, Gabriel Woerle, Hans J Broedl, Uli C